This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May;12(5):255.

doi: 10.1038/nrcardio.2015.40. Epub 2015 Mar 31.

Valvular disease. RCTs inform on 5-year outcomes with TAVR and its use in patients at low surgical risk

Bryony M Mearns

PMID: 25824507
DOI: 10.1038/nrcardio.2015.40

Comment

Valvular disease. RCTs inform on 5-year outcomes with TAVR and its use in patients at low surgical risk

Bryony M Mearns. Nat Rev Cardiol. 2015 May.

. 2015 May;12(5):255.

doi: 10.1038/nrcardio.2015.40. Epub 2015 Mar 31.

Author

Bryony M Mearns

PMID: 25824507
DOI: 10.1038/nrcardio.2015.40

No abstract available

PubMed Disclaimer

Comment on

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, Webb JG, Mack MJ, Douglas PS, Thourani VH, Babaliaros VC, Herrmann HC, Szeto WY, Pichard AD, Williams MR, Fontana GP, Miller DC, Anderson WN, Akin JJ, Davidson MJ, Smith CR; PARTNER trial investigators. Kapadia SR, et al. Lancet. 2015 Jun 20;385(9986):2485-91. doi: 10.1016/S0140-6736(15)60290-2. Epub 2015 Mar 15. Lancet. 2015. PMID: 25788231 Clinical Trial.

References

1. J Am Coll Cardiol. 2015 May 26;65(20):2184-94 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.